Day One Biopharmaceuticals
DAWN
DAWN
156 hedge funds and large institutions have $1.03B invested in Day One Biopharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 48 increasing their positions, 48 reducing their positions, and 24 closing their positions.
Holders
156
Holders Change
+7
Holders Change %
+4.7%
% of All Funds
2.27%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
33
Increased
48
Reduced
48
Closed
24
Calls
$3.07M
Puts
$4.45M
Net Calls
-$1.38M
Net Calls Change
-$1.39M
Top Buyers
| 1 |
VPC
1
Vestal Point Capital
New York
|
$17.2M |
| 2 |
DM
2
Deerfield Management
New York
|
$40.3M |
| 3 |
ECM
3
Estuary Capital Management
Wayzata,
Minnesota
|
$36.3M |
| 4 |
B
4
Braidwell
Stamford,
Connecticut
|
$41.8M |
| 5 |
ABG
5
Ally Bridge Group
New York
|
$7.39M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MLICM
176
Metropolitan Life Insurance Company (MetLife)
New York
| – | – | -3,691 | Closed |
|
|
EC
177
EntryPoint Capital
New York
| – | – | -582 | Closed |
|
178
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | – | -14 | Closed |
|
|
AWM
179
Avior Wealth Management
Omaha,
Nebraska
| – | – | -12 | Closed |
|
180
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
CFGS
181
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
C
182
Covestor
London,
United Kingdom
| $0 | 7 | – | – |
|